Asensus Surgical US, Inc.
USPTO PatentsView assignee record - 58 granted patents across 12 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Asensus ranks #5,819 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 12 technology areas.
- #5,819
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (53.9/100)
- 12.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R5819 · US Corporation #5,819 · 58 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 58 grants
- UPPER-Q #5,819/49,997
- PHOTO-FINISH Alpha and Omega…
- CPC-FOCUS A61B · 12 areas
- INNOV-PAR 53.9/100
- CLAIMS-RICH 12.6 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Alpha and Omega Semiconductor International LP (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Asensus’s 53.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Asensus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cfph · near
Cfph · near
54 score
- John Mezzalingua… · near
John Mezzalingua… · near
54 score
- ABB · near
ABB · near
54 score
- Asensus Surgical US · this assignee
Asensus Surgical US · this assignee
54 score
- Behr Process · near
Behr Process · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Asensus's Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Asensus?
Each dot is one of Asensus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Asensus’s own 12.6 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Asensus's grants concentrate
Asensus Surgical US, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (16 grants) versus a trough of 7 in 2021. By volume, Asensus sits between Avigilon Fortress Corporation and Collateral Opportunities, LLC.
Asensus's three-year grant acceleration
Asensus Surgical US, Inc. shows 41 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Asensus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Avigilon Fortress
Avigilon Fortress Corporation
58 patents
- Alpha and Omega S…
Alpha and Omega Semiconductor International LP
58 patents
- Amphipod
Amphipod, Inc.
58 patents
- Andis
Andis Company
58 patents
- Aydeekay
AyDeeKay LLC
58 patents
- Berg Companies
Berg Companies, Inc.
58 patents
- Cerence Operating
Cerence Operating Company
58 patents
- Collateral Opport…
Collateral Opportunities, LLC
58 patents
- Asensus Surgical… ◀
Asensus Surgical US, Inc.
58 patents
What this shows Asensus holds 58 patents at rank #5,821, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Asensus
By rank, the assignees closest to #5,821 in granted patent volume.
- Avigilon Fortress Corporation #5,817 · 58 patents
- Alpha and Omega Semiconductor International LP #5,818 · 58 patents
- Amphipod, Inc. #5,819 · 58 patents
- Andis Company #5,820 · 58 patents
- AyDeeKay LLC #5,822 · 58 patents
- Berg Companies, Inc. #5,823 · 58 patents
- Cerence Operating Company #5,824 · 58 patents
- Collateral Opportunities, LLC #5,825 · 58 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Asensus's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Asensus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Asensus ranks #320 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (12.6 here).
Asensus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 7 | 12.1% |
| 2022 | 9 | 15.5% |
| 2023 | 16 | 27.6% |
| 2024 | 16 | 27.6% |
| 2025partial year | 10 | 17.2% |
Which technologies does Asensus Surgical US, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Asensus Surgical US, Inc.'s patent record in context - here's where to go next.
- Asensus Surgical US, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #5,819 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Asensus Surgical US, Inc. against Avigilon Fortress Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.